http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101250464-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2814 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-948 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 |
| filingDate | 2010-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101250464-B1 |
| titleOfInvention | A method for the diagnosis of Alzheimer＇s disease from determination of PGCP concentration in human plasma |
| abstract | The present invention relates to a method for diagnosing dementia by measuring the concentration of PGCP present in plasma. More specifically, by confirming that PGCP is present in plasma of dementia patients at a significantly higher concentration than in normal and mild cognitive impairment groups, By using the PGCP protein as a diagnostic marker to configure a dementia diagnostic kit, it can be usefully used in the dementia diagnostic method. |
| priorityDate | 2010-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 395.